1,812 reports of this reaction
2.4% of all FILGRASTIM reports
#10 most reported adverse reaction
FATIGUE is the #10 most commonly reported adverse reaction for FILGRASTIM, manufactured by Amgen, Inc. There are 1,812 FDA adverse event reports linking FILGRASTIM to FATIGUE. This represents approximately 2.4% of all 76,865 adverse event reports for this drug.
Patients taking FILGRASTIM who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for FILGRASTIM, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for FILGRASTIM:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,812 FDA reports for FILGRASTIM. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.4% of all adverse event reports for FILGRASTIM, making it a notable side effect.
If you experience fatigue while taking FILGRASTIM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.